BVF Inc/il, Director Other at Kymera Therapeutics, Inc. (KYMR), bought 424,505 shares at $19.60 ($8.3M) on 2022-05-05, disclosed to the SEC on 2022-05-09.
Open-market purchase of $8.3M KYMR by Director Other. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.60 | 4,066 | $80K | 1.0% |
| 2 | $19.60 | 4,066 | $80K | 1.0% |
| 3 | $19.60 | 70,439 | $1.4M | 16.7% |
| 4 | $19.60 | 70,439 | $1.4M | 16.7% |
| 5 | $19.60 | 75,495 | $1.5M | 17.9% |
| 6 | $19.26 | 4,131 |
| $80K |
| 1.0% |
| 7 | $19.26 | 4,131 | $80K | 1.0% |
| 8 | $19.26 | 40,659 | $783K | 9.5% |
| 9 | $19.26 | 40,659 | $783K | 9.5% |
| 10 | $19.26 | 55,210 | $1.1M | 12.9% |
| 11 | $19.26 | 55,210 | $1.1M | 12.9% |
| Total | $19.44 avg | 424,505 | $8.3M | 100% |
| Filing → |
| PNT | SELL | 2023-12-20 | $427.3M | — | Filing → |
| CGEM | BUY | 2022-05-16 | $20.1M | — | Filing → |
| KYMR | BUY | 2022-01-31 | $10.2M | — | Filing → |